JDBIO
Richesse PLA
Brand
JDBIO
Category
Biostimulator (PLLA/PCL)
Origin
Korea
Interested in ordering Richesse PLA? Send an enquiry and our team will follow up with availability and pricing.
Used in
Overview
Richesse PLA is a polylactic acid (PLA/PLLA) collagen biostimulator from the Korean aesthetics brand JDBIO, formulated with roughly 200 mg of PLA plus carboxymethylcellulose per vial. Marketed as a biodegradable stimulator for gradual volume enhancement, its effect is generated through neocollagenesis and is reported to last well over a year. It is intended for mid-face volumisation and treatment of laxity.
How it works
The PLA microparticles function as a resorbable scaffold that provokes a measured fibroblast response, stimulating new collagen deposition in the dermis. The carrier gel is absorbed while the newly formed collagen provides sustained, natural volume. Results appear gradually over the weeks following each session and accumulate across a treatment course.
Indications
- Mid-face volume loss
- Skin laxity
- Deep wrinkles and folds
- Age-related collagen depletion
- Natural facial rejuvenation
Key features
- Polylactic acid (PLA/PLLA) collagen biostimulator, ~200 mg per vial
- Biodegradable, resorbable synthetic scaffold
- PLA sourced from renewable plant starch (corn/potato)
- Progressive neocollagenesis rather than instant fill
- CE-certified; for licensed practitioners only
Benefits
- Adds a biostimulator option to the injectable menu
- Natural, gradual correction supports repeat treatment courses
- Reported longevity of 18+ months reinforces patient value
- Fully resorbable synthetic with a predictable resorption profile
- Backed by an established Korean aesthetic brand (JDBIO)
Composition
Polylactic acid (PLA/PLLA), approximately 200 mg with sodium carboxymethylcellulose (CMC) per vial; PLA derived from renewable plant-starch sources.
Usage & handling
Reconstitute and hydrate per manufacturer instructions before use. Inject into the deep dermis or subcutaneous plane and massage to distribute evenly. Effect develops progressively over weeks; a course of sessions spaced roughly a month apart is typical, with volumising effect reported to last 18 months or more.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.